Literature DB >> 11692064

Immunohistochemical detection of 8-hydroxy-2'-deoxyguanosine in gallbladder epithelium of patients with pancreaticobiliary maljunction.

K Otani1, S Shimizu, K Chijiiwa, K Yamaguchi, H Noshiro, M Tanaka.   

Abstract

OBJECTIVES: Pancreaticobiliary maljunction, an anomalous union of the pancreatic duct with the common bile duct, is a risk factor for biliary carcinoma. We hypothesized that, in patients with pancreaticobiliary maljunction, persistent regurgitation of pancreatic juice into the biliary tract induces oxidative DNA damage. We assessed the expression of an oxidative DNA base-modified product, 8-hydroxy-2'-deoxyguanosine, in gallbladder epithelium.
DESIGN: Eleven noncancerous gallbladders from patients with pancreaticobiliary maljunction, 12 gallbladder carcinomas from patients without pancreaticobiliary maljunction and 14 noncancerous gallbladders from patients without pancreaticobiliary maljunction (control) were studied.
METHODS: Immunohistochemistry was performed for 4-hydroxy-2-nonenal-modified protein (as a marker for lipid peroxidation), 8-hydroxy-2'-deoxyguanosine and p53 gene product.
RESULTS: Stronger cytoplasmic staining of 4-hydroxy-2-nonenal-modified protein was observed in the gallbladder epithelium from patients with pancreaticobiliary maljunction than in epithelium from gallbladder cancer patients or from control subjects with normal gallbladders. Clear, strong nuclear staining of 8-hydroxy-2'-deoxyguanosine was observed in the gallbladder epithelial cells from patients with pancreaticobiliary maljunction. Densitometric quantitation revealed significantly higher expression of 8-hydroxy-2'-deoxyguanosine in gallbladder epithelial cells from patients with pancreaticobiliary maljunction (index 27.3 +/- 3.1) than in cells from patients with gallbladder carcinoma (11.4 +/- 1.5; P < 0.05) or from control subjects with normal gallbladder (6.4 +/- 1.0; P < 0.05). Positivity of p53 was 27% in gallbladder epithelium associated with pancreaticobiliary maljunction, 75% in gallbladder carcinoma epithelium and 0% in control epithelium.
CONCLUSIONS: These results suggest that reactive oxygen species are produced in the gallbladder of patients with pancreaticobiliary maljunction and that oxidative DNA injury is related to carcinogenesis in these patients.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11692064     DOI: 10.1097/00042737-200111000-00016

Source DB:  PubMed          Journal:  Eur J Gastroenterol Hepatol        ISSN: 0954-691X            Impact factor:   2.566


  5 in total

Review 1.  Pancreaticobiliary maljunction and carcinogenesis to biliary and pancreatic malignancy.

Authors:  Takahiko Funabiki; Toshiki Matsubara; Shuichi Miyakawa; Shin Ishihara
Journal:  Langenbecks Arch Surg       Date:  2008-05-24       Impact factor: 3.445

2.  Oxidative DNA damage in peripheral leukocytes and its association with expression and polymorphisms of hOGG1: a study of adolescents in a high risk region for hepatocellular carcinoma in China.

Authors:  Tao Peng; Han-Ming Shen; Zhi-Ming Liu; Lu-Nan Yan; Min-Hao Peng; Le-Qun Li; Ren-Xiang Liang; Zong-Liang Wei; Barry Halliwell; Choon Nam Ong
Journal:  World J Gastroenterol       Date:  2003-10       Impact factor: 5.742

Review 3.  Oxidative Stress: A New Target for Pancreatic Cancer Prognosis and Treatment.

Authors:  Javier Martinez-Useros; Weiyao Li; Marticela Cabeza-Morales; Jesus Garcia-Foncillas
Journal:  J Clin Med       Date:  2017-03-09       Impact factor: 4.241

4.  Altered expression levels of occludin, claudin-1 and myosin light chain kinase in the common bile duct of pediatric patients with pancreaticobiliary maljunction.

Authors:  Shun-Gen Huang; Wan-Liang Guo; Zhi-Cheng Zhou; Jun-Jie Li; Fu-Bin Yang; Jian Wang
Journal:  BMC Gastroenterol       Date:  2016-01-16       Impact factor: 3.067

5.  Impact of DNA double-strand breaks on pancreaticobiliary maljunction carcinogenesis.

Authors:  Yasuhiro Kuraishi; Takeshi Uehara; Takashi Muraki; Mai Iwaya; Yasuhiro Kinugawa; Tomoyuki Nakajima; Takayuki Watanabe; Yusuke Miyagawa; Takeji Umemura
Journal:  Diagn Pathol       Date:  2021-08-09       Impact factor: 2.644

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.